Patents Assigned to NANO TARGETING & THERAPY BIOPHARMA INC.
  • Method for delivering an agent to posterior segment of an eye and uses thereof
    Patent number: 12016958
    Abstract: The disclosure provides a method for delivering an agent to posterior segment of an eye comprising administrating a pharmaceutical composition comprising the agent and mesoporous silica nanoparticles to the eye. An eye drop and a method for treating an ocular disease in a subject in need of such treatment are also provided.
    Type: Grant
    Filed: February 25, 2022
    Date of Patent: June 25, 2024
    Assignee: NANO TARGETING & THERAPY BIOPHARMA INC.
    Inventors: Cheng-Hsun Wu, Si-Han Wu, Yi-Ping Chen, Rong-Lin Zhang, Tien-Chun Yang, Chung-Yuan Mou, Hardy Wai Hong Chan
  • Surface-modified mesoporous silica nanoparticle for blood-brain barrier penetration,tumor targeting and cancer metastasis treatment, methods of production and uses thereof
    Patent number: 11419826
    Abstract: The present disclosure relates to mesoporous silica nanoparticles (MSNs) with specific modifications as drug delivery systems containing both tumor targeting and blood-brain barrier (BBB) penetration properties suitable for cancer treatment and/or CNS disease treatment. The present disclosure also relates to method of preparing MSNs and the MSNs prepared by the method as described herein.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: August 23, 2022
    Assignee: NANO TARGETING & THERAPY BIOPHARMA INC.
    Inventors: Cheng-Hsun Wu, Yi-Ping Chen, Si-Han Wu, Chung-Yuan Mou